George Parise, CFO of Princeton BioPharma LLC, Barry Lederman, CFO of Halo Pharma, Andrew Einhorn, CFO of Edge Therapeutics, Jim Mastakas, SVP & CFO of Amneal Pharmaceuticals, and Brian Zietsman, President & CFO of Enteris BioPharma will be presenting Bio-tech and Pharma discussion, moderated by Mark Giamo, New Jersey Office Managing Partner, BDO, at 3:15 P.M., May 5th, MetLife Stadium, East Rutherford, NJ.CFOs and senior finance executives may attend at no cost, and non-CFOs may purchase tickets, by registering at www.CFOstudio.com.

Mark Giamo, New Jersey Office Managing Partner, BDO

In his role as New Jersey Office Managing Partner for BDO USA, LLP, Mark is responsible for managing all aspects of the assurance practice for BDO’s New Jersey Office. Mark also co-leads the NY Metro Technology Practice. Mark joined BDO in 1997 and has serviced publicly-traded, private, multi-national, private equity sponsored and growth-oriented companies in the technology industry. Mark spends a significant amount of time servicing SEC registrants as both the engagement partner and technical partner reviewer. In addition, Mark acts as an instructor for continuing education and plays an active role in the firm’s internal quality inspection program.

 Some of Mark’s professional affiliations include American Institute of Certified Public Accountants (AICPA), New Jersey State Society of Certified Public Accountants, Board of Directors, Special Olympics of New Jersey, and the Board of Directors, New Jersey Technology Council.

 Mark received a B.S. in Accounting from Villanova University.

Barry Lederman, Chief Financial Officer, Halo Pharma

Barry Lederman has extensive financial and international pharmaceutical experience, having led teams of several public and private companies with global operations. Prior to joining Halo, he served as the Vice President and CFO for Eisai Inc. with operations in the Americas Region, the CFO at Wedgewood Pharmacy, Nycomed US Inc., and Qualitrol Company LLC (a subsidiary of Danaher Corporation). He also spent 10 years with Roche in positions of increasing responsibility within Finance, culminating in his appointment as Senior Vice President – Head of Business Analysis and Controlling at Roche Centralized Diagnostics, headquartered in Mannheim, Germany. He is a CPA licensed in New Jersey and New York and gained his accounting experience at PwC.

Andrew Einhorn, Chief Financial Officer, Edge Therapeutics

Andrew Einhorn is the Chief Financial Officer of Edge Therapeutics, Inc. Previously, he served as the Executive Vice President, Corporate Development of the company. Mr. Einhorn has more than 10 years of experience in the pharmaceutical industry developing and executing corporate strategy. He also has more than 20 years of experience as an investment banker working extensively in corporate finance, capital markets and financial analysis. His experience includes numerous acquisition and licensing transactions across a variety of therapeutic areas and geographies.

 Prior to joining Edge Therapeutics, Mr. Einhorn was an independent consultant, served as CFO at Myos Corporation and was the Executive Vice President and Chief Financial Officer at Oceana Therapeutics, Inc.

 Mr. Einhorn was licensed as a Certified Public Accountant in New Jersey and a graduate of The American University where he completed a double major in Finance and Accounting.

Jim Mastakas, Senior Vice President and Chief Financial Officer, Amneal Pharmaceuticals

Jim oversees the global financial operations of the organization, including strategic planning, budgeting and forecasting, investment decisions, external financing, debt compliance, financial analysis and tax planning. In addition, he is responsible for the IT function. Jim has more than 18 years of experience in the pharmaceutical industry, including thirteen years in generics and specialty sectors. Prior to joining Amneal, Jim was chief financial officer at Sandoz NA, Eagle Pharmaceuticals and Corepharma, and vice president/controller for Mylan’s generic business. He also spent five years at Wyeth leading their External Reporting team. Jim holds a bachelor’s degree in accountancy from Bentley University and is a certified public accountant.

Brian Zietsman, President & Chief Financial Officer, Enteris BioPharma

Mr. Brian Zietsman, President and Chief Financial Officer, joined the Company in July 2013. He brings more than 20 years of strategic finance and accounting experience to his position, over half of which has been in the pharmaceutical industry for both public and private companies.

Prior to joining Enteris BioPharma, Mr. Zietsman was the Chief Financial Officer of Unigene Laboratories, Inc. where he played a pivotal role in that company’s restructuring. Prior to working at Unigene, he was the Corporate Controller at Duff & Phelps (NYSE DUF) and between 2005 and 2011, he worked in various financial capacities at Enzon Pharmaceuticals, Inc., (NASDAQ – ENZN), including Vice President and Corporate Controller. Prior to Enzon, Mr. Zietsman was the Corporate Controller at Reliant Pharmaceuticals, Inc., a privately held company which was acquired by GlaxoSmithKline, and earlier worked at Deloitte where he held various positions of increasing responsibility, leaving as a Senior Manager in the audit group.

Mr. Zietsman is a graduate from Rhodes University, South Africa where he earned his B. Com (Accounting), BSc (Computer Science) and HDIPACC certifications. Mr. Zietsman is a registered CPA.

Claude Draillard, CFO of Dassault Falcon Jet, Bill Flynn, CFO of Sharp Electronics, and Michael Mardy, CFO of TUMI will lead panel “Global Companies: Unique Challenges and Opportunities” moderated by PWC at 3:15 P.M., May 5th, MetLife Stadium, East Rutherford, NJ. CFOs and senior finance executives may attend at no cost, and non-CFOs may purchase tickets, by registering at www.CFOstudio.com.

Claude Draillard, CFO, Dassault Falcon Jet

Claude Draillard is an accomplished, global executive with over twenty years of finance experience in the Aviation, Manufacturing, and Financial Services industries.  He has an impressive track record in increasing profit-margins and cash flow, as well as performance improvement, operational streamlining, and negotiating financing/leasing.

 Claude currently serves as VP, Finance (i.e. CFO) at Dassault Falcon Jet, part of the worldwide Dassault Group of Companies, managing $2 billion US in annual revenues.  As CFO, Claude oversees and manages all aspects of financial operations, including cost-control, risk management, price-determination, financing for expansion and relocation projects, financial reporting. He is also in charge of IT.  He runs an international team of over 150 employees.  Claude also led the development and promotion of a cost reduction plan that reduced company labor expenses by 30%.

 Claude has been with the Dassault Group since 1994, and has served in all types of finance positions.  He has an M Phil in Marketing and Strategy from Université Paris IX DAUPHINE and is a graduate from ESSEC, an MBA accredited Business School in France.  Claude is fluent in French, and conversational in German. Claude was featured in the 3rd quarter 2014 issue of CFO Studio, in an article titled “Flying High”.  He lives in New York City with his wife, Karyn.

Bill Flynn, CFO, Sharp Electronics

Bill Flynn joined Sharp in 2005 and has over 25 years of Accounting and Financial experience.   He is currently Sr. VP/CFO for Sharp America’s operations and leads the finance, CIO, and facility organizations for Sharp in this region.  Bill is actively involved with Sharp’s three primary businesses in the America’s Region:  consumer electronics, document, and devices.

Michael Mardy, CFO, Tumi

Mr. Michael J. Mardy, also known as Mike, has been the Chief Financial Officer and Executive Vice President at Tumi Holdings, Inc. since July 2003 and serves as its Principal Accounting Officer. Mr. Mardy has been Senior Vice President and Chief Financial Officer of Tumi, Inc. since July 2003 and serves as its Chief Technology Officer. From 1996 to 2002, Mr. Mardy served as an Executive Vice President and Chief Financial Officer of Keystone Foods LLC, a global manufacturer of food products. From 1980 to 1996, he served in various positions with Nabisco, Inc., last serving as Senior Vice President and Chief Financial Officer of Nabisco Biscuit Company. Mr. Mardy serves as an Interim Chairman of TC Global, Inc. He served as an Interim Chairman of the Board at Green Mountain Coffee Roasters Inc. from May 2012 to December 12, 2012. He has been a Director of Tumi Holdings, Inc. since November 2011. He serves as a Director of ModusLink Corporation. He has been a Director of Green Mountain Coffee Roasters Inc. since April 3, 2007. Mr. Mardy also serves on the board of the Institute of Medicine and Public Health for New Jersey. He served as a Director of ModusLink Global Solutions, Inc. (formerly CMGI Inc.) since May 2003. Mr. Mardy is a Member of the American Institute of Certified Public Accountants, the New Jersey State Society of CPAs, and the Financial Executives Institute. Mr. Mardy graduated from Princeton University in 1970 with a B.A. in History and holds an M.B.A. in Accounting and Finance from Rutgers University in 1976.

Robert Half’s Dawn Fay, District President, to lead discussion entitled “Accelerate Your Career: CFO Salary Trends, In-Demand Skills, and Opportunities for Success” at 11:00 A.M., May 5th, MetLife Stadium, East Rutherford, NJ. CFOs and senior finance executives may attend at no cost, and non-CFOs may purchase tickets, by registering at www.CFOstudio.com.

Dawn Fay, District President, Robert Half

Dawn Fay is the District President for the Tri-State Area of Robert Half, the world’s first and largest specialized staffing firm. Dawn oversees Robert Half’s Professional Staffing Services operations in 18 locations across New York, New Jersey and Connecticut. Her primary areas of focus are the company’s three financial lines of business; Robert Half Finance & Accounting, Accountemps and Robert Half Management Resources.

 Since joining Robert Half in 1996, Dawn has climbed the ranks and held roles of increasing responsibility in cities including Charlotte and Atlanta. In 2005, Dawn was promoted to NYC Metro Market Manager, where she was responsible for the Midtown, NY office, the company’s largest branch. Just a year later, Dawn was promoted to Regional Vice President for the NY Metro Market and in 2009 was promoted to President, overseeing all offices in the Tri-State area.

 Dawn serves as a national spokesperson for Robert Half and has been featured in several top publications, including the Wall Street Journal, New York Times, USA Today, and Crain’s New York Business. She has also made appearances on local and national broadcast networks, including CBS News and FOX. Dawn is considered a local expert on the staffing industry, commenting on recruiting practices, hiring trends, and other workplace issues.

 Prior to joining Robert Half, Dawn worked as a financial analyst in New York City and Washington, DC. Dawn earned her bachelor’s degree in economics at The George Washington University.